CD8A and neoplasm: Remarkably, there was an apparent reduction in tumor growth in mice immunized with C16:0 peptides compared to peptide counterparts (Figure 2C), although no differences were found in the frequency of antigen-specific CD8+ T cells in the blood on day 7 after vaccination (data not shown).